EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients

Ahmed M I Elfiky iD, Hidde M Smits iD, Marlot van der Wal, Coco Dekkers iD, Celeste M Boesjes iD, Julia Drylewicz iD, Marjolein de Bruin-Weller iD, Femke van Wijk

Clinical & Experimental Allergy · 2026-11 · 56 (11) · 1452-1455

DOI: 10.1111/cea.70397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 15.07.2026. Verfasst von Ahmed M I Elfiky und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health~Holland, the Top Sector Life Sciences & Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skin‐homing T‐helper cells show a unique DNA methylome in AD. Dupilumab partially corrects, whereas upadacitinib broadens methylation differences and reinforces AD‐related methylation signatures.

Autor:innen und Institutionen

  • Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID-Profile: Ahmed M I Elfiky, Hidde M Smits, Coco Dekkers, Celeste M Boesjes, Julia Drylewicz, Marjolein de Bruin-Weller

Förderung

  • Health~Holland, the Top Sector Life Sciences & Health

Zitieren

APA

Elfiky, A. M. I., Smits, H. M., van der Wal, M., Dekkers, C., Boesjes, C. M., Drylewicz, J., de Bruin-Weller, M., & van Wijk, F. (2026). Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients. Clinical & Experimental Allergy, 56(11), 1452-1455. https://doi.org/10.1111/cea.70397

Vancouver

Elfiky AMI, Smits HM, van der Wal M, Dekkers C, Boesjes CM, Drylewicz J, et al. Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients. Clinical & Experimental Allergy. 2026;56(11):1452-1455. doi:10.1111/cea.70397

BibTeX
@article{Elfiky2026,
  author = {Elfiky, Ahmed M I and Smits, Hidde M and van der Wal, Marlot and Dekkers, Coco and Boesjes, Celeste M and Drylewicz, Julia and de Bruin-Weller, Marjolein and van Wijk, Femke},
  title = {Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients},
  journal = {Clinical & Experimental Allergy},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {1452--1455},
  doi = {10.1111/cea.70397}
}
Kostenlos starten →